Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Psilocybin is a promising pharmaceutical compound that is currently undergoing development for therapeutical use in Canada. Many people who take psilocybin report heightened sensation, improved perception, and better focus after taking a micro-dose (e.g., 10-20% of the full clinical dose). Atlhough micro-dosing has gain popularity in neuro-hacking circles and in some popular literature, very few studies quantified the effects of microdosing on sensory perception. The goal of this study is to explore if people who actively engage in micro-dosing perfrom differently on multisensory and time-related perceptual tasks after taking a microdose. The goal of this research is to understand the dosing protocols in current users and the if the qualitative effects of micro-dosing can be
captured. This research will provide LTG with critical data for their psilocybin supplement development and provide the intern with a rich experience in applied psychological research.
Gerome Manson
LongTermGevity Inc.
Life Sciences
Professional, scientific and technical services
Queen's University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.